NRXS vs VASO: stock comparison and AI forecast
Neuraxis, Inc (NRXS) and Vaso Corp (VASO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NRXS Neuraxis, Inc
- Price
- $6.11 -30.6% · 6M
- Market Cap
- $77M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
VASO Vaso Corp
- Price
- $0.29 +61.1% · 6M
- Market Cap
- $51M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- NRXS is 1.5 times larger than VASO by market capitalization ($77M against $51M).
- Over the last six months VASO returned +61.1% and NRXS -30.6%.
- VASO turns 3.1% of its revenue into net income, against -144.4% for NRXS.
- VASO carries 1.94 times debt per unit of equity, against 0.48 times for NRXS.
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NRXS | VASO |
|---|---|---|
| Market Cap | $77M | $51M |
| P/B Ratio | 11.39x | 1.75x |
| EPS | $-0.92 | $0.00 |
| Book Value/Share | $0.54 | $0.17 |
| Revenue/Share | $0.42 | $0.46 |
Profitability & Margins
| Metric | NRXS | VASO |
|---|---|---|
| ROE | -114.0% | 8.6% |
| ROA | -76.8% | 2.9% |
| ROIC | -111.3% | -3.0% |
| Gross Margin | 85.6% | 64.8% |
| Operating Margin | -144.5% | -2.0% |
| Net Margin | -144.4% | 3.1% |
| EBT Margin | -144.5% | 0.1% |
| Tax Rate | -0.3% | -7252.6% |
Financial Health
| Metric | NRXS | VASO |
|---|---|---|
| Current Ratio | 3.04x | 1.68x |
| Quick Ratio | 2.95x | 1.65x |
| D/E Ratio | 0.48x | 1.94x |
| Financial Leverage | 1.48x | 2.94x |
| Interest Coverage | -107.3x | -116.2x |
| Working Capital | $6M | $22M |
Cash Flow
| Metric | NRXS | VASO |
|---|---|---|
| Operating Cash Flow | -$6M | $8M |
| OCF Growth YoY | – | 0.9% |
Operational Efficiency
| Metric | NRXS | VASO |
|---|---|---|
| Asset Turnover | 0.53x | 0.93x |
| Receivables Turnover | 12.3x | 24.0x |
| Inventory Turnover | 2.8x | 33.7x |
| Fixed Assets Turnover | 81.2x | 794.3x |
| Days Sales Outstanding | 30 days | 15 days |
| Days Inventory | 132 days | 11 days |
| Payables Period | 376 days | 9 days |
| Cash Conversion Cycle | -215 days | 17 days |
Income Statement
| Metric | NRXS | VASO |
|---|---|---|
| Total Revenue | $5M | $80M |
| Operating Income | -$8M | -$2M |
| Net Income | -$8M | $2M |
| R&D Expense | $750K | $780K |
| SG&A Expense | $11M | $48M |
| Cost of Goods Sold | $770K | $28M |
Dividend & Shareholder Information
| Metric | NRXS | VASO |
|---|---|---|
| Shares Outstanding | 13M | 176M |
| EPS Growth | – | -100.0% |
NRXS vs VASO: stock comparison and AI forecast
Which is bigger, NRXS or VASO?
NRXS is 1.5 times larger than VASO by market capitalization ($77M against $51M).
Which stock performed better over the last six months, NRXS or VASO?
Over the last six months VASO returned +61.1% and NRXS -30.6%.
Which one does Intratio's AI model rank higher, NRXS or VASO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.